[at TheStreet] – Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors. Read more on this. Biogen Inc. (BIIB), with a current . . . → Read More: Market Update (NASDAQ:BIIB): Cramer — Be Careful Buying GrubHub, Biogen Is a Battleground Similar Articles: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen 2015 Annual Shareholder Meeting Webcast Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair